Joseph E. Payne, President and CEO at Arcturus Therapeutics Holdings Inc. (ARCT), bought 5,000 shares at $11.22 ($56K) on 2019-08-29, disclosed to the SEC on 2019-08-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ARCT | BUY | 2020-06-10 | $32K | — | Filing → |